Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCHW) Free Cash Flow (2022 - 2025)

Historic Free Cash Flow for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to -$4.4 million.

  • Envoy Medical's Free Cash Flow fell 2183.59% to -$4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.1 million, marking a year-over-year increase of 3292.74%. This contributed to the annual value of -$18.9 million for FY2024, which is 977.15% down from last year.
  • Per Envoy Medical's latest filing, its Free Cash Flow stood at -$4.4 million for Q3 2025, which was down 2183.59% from -$4.5 million recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Free Cash Flow ranged from a high of $1.0 million in Q3 2023 and a low of -$11.2 million during Q4 2023
  • Its 4-year average for Free Cash Flow is -$3.8 million, with a median of -$4.0 million in 2023.
  • The largest annual percentage gain for Envoy Medical's Free Cash Flow in the last 5 years was 11974.07% (2023), contrasted with its biggest fall of 91085.32% (2023).
  • Over the past 4 years, Envoy Medical's Free Cash Flow (Quarter) stood at -$2.4 million in 2022, then crashed by 361.4% to -$11.2 million in 2023, then soared by 59.19% to -$4.6 million in 2024, then increased by 3.88% to -$4.4 million in 2025.
  • Its Free Cash Flow was -$4.4 million in Q3 2025, compared to -$4.5 million in Q2 2025 and -$3.7 million in Q1 2025.